Medtechwest is involved in the development and promotion of medical technology innovations, including dental implants that generate electricity and surgical procedures using augmented reality.

Medtechwest

Flow Medical develops innovative medical technology for interventional pulmonary embolism treatment, focusing on personalized and precise medicine.

Flow Medical

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Maxwell Becton

Fairleigh Dickinson

Becton, Dickinson and Company

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

Metric
Company Name	Medtechwest	Flow Medical	Becton, Dickinson and Company	DexCom, Inc.
Symbol			BDX	DXCM
MSH ID	SE:MEDTECHWEST	CO:FLOWMEDICAL	COM:BD	COM:DEXCOM
Market	PRIVATE	PRIVATE	STOCKS	STOCKS
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare	Healthcare
Industry	Medical Devices	Medical Devices	Medical - Instruments & Supplies	Medical - Devices
Country	SE	US	US	US
Stage
Employee Count			70K	9.50K
Website	medtechwest.se	flowmedical.co	bd.com	dexcom.com
LinkedIn			bd1	dexcom
Founders

Metric
Market Cap	64.70B	44.06B
Enterprise Value
Monthly Web Traffic		4.27M
Web Traffic Growth		1.06
Valuation
Raised Capital		1B

Metric
Revenue	20.18B	3.62B
Revenue (LTM)
Revenue (NTM)
Gross Profit	20.18B	2.29B
EBITDA	2.42B	916.70M
Operating Income	2.42B	597.70M
Net Income	1.73B	541.50M
EPS	5.96	1.40
Diluted EPS	5.93	1.30
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.55	0.63
Operating Profit Margin	0.12	0.17
EBITDA Margin	0.12	0.25
Net Profit Margin	0.07	0.17
Return on Equity	0.06	0.30
Return on Assets	0.03	0.10
Return on Capital Employed	0.05	0.13

MEDT

SE:MEDTECHWEST

Medtechwest

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	54.49	124.03
P/B Ratio	2.70	20.62
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	3.63	14.04
EV Multiple	15.21	61.92

Metric
Days Sales Outstanding	42.45	84.27
Days Payables Outstanding		407.66
Days Inventory Outstanding	105.52	153.18
Operating Cycle	151.20	252.69
Cash Conversion Cycle	47.37	177.03
Asset Turnover	0.37	0.59

Metric
Operating Cash Flow	3.84B	748.50M
Free Cash Flow	3.12B	511.90M
Cash Flow to Debt	0.21	0.36
Operating Cash Flow/Sales	0.20	0.23
Free Cash Flow Yield	0.04	0.01

Metric
Cash & Equivalents	1.86B	566.30M
Accounts Receivable		-260.10M
Inventory	3.84B	559.60M
Goodwill	26.46B	25.20M
Debt to Capitalization	0.43	0.56
Debt to Assets	0.33	0.40
Current Ratio	1.08	2.80
Quick Ratio	1.36	2.53

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01	0.04
R&D to Revenue	0.06	0.14
SG&A to Revenue